Kobayashi S, Ogren S O, Ebendal T, Olson L
Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
Eur J Pharmacol. 1997 May 12;326(1):1-5. doi: 10.1016/s0014-2999(97)83487-5.
The role of dopamine receptors in mediating nerve growth factor (NGF)-induced locomotor stimulation was investigated by examining the effects of selective dopamine D1 and D2 receptor antagonists on the motor hyperactivity induced by NGF. A single intracerebroventricular administration of NGF (5.1 microg) increased locomotor activity immediately after injection in normal adult rats. This hyperactivity was partly blocked by the dopamine D1 receptor antagonist SCH23390 (R-(+)-7-chloro-2,3,4,5-tetrahydro-3-methyl-1-phenyl-1H-3-benzazepine-8- ol) and by the dopamine D2 antagonist raclopride ((S)-3,5-dichloro-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-hydroxy-6-methoxy benzamide). Effective doses of raclopride did not alter spontaneous levels of activity in control rats. These results suggest that stimulation of both subtypes of dopamine receptors is necessary for eliciting NGF-induced hyperactivity in the rat. The role of the dopamine D2 receptor in mediating the behavioral actions of NGF appears to be more important than that of the dopamine D1 receptor.
通过检测选择性多巴胺D1和D2受体拮抗剂对神经生长因子(NGF)诱导的运动亢进的影响,研究了多巴胺受体在介导NGF诱导的运动刺激中的作用。在正常成年大鼠中,单次脑室内注射NGF(5.1微克)后立即增加了运动活性。多巴胺D1受体拮抗剂SCH23390(R-(+)-7-氯-2,3,4,5-四氢-3-甲基-1-苯基-1H-3-苯并氮杂卓-8-醇)和多巴胺D2拮抗剂雷氯必利((S)-3,5-二氯-N-((1-乙基-2-吡咯烷基)甲基)-2-羟基-6-甲氧基苯甲酰胺)部分阻断了这种运动亢进。雷氯必利的有效剂量并未改变对照大鼠的自发活动水平。这些结果表明,刺激多巴胺受体的两种亚型对于引发大鼠NGF诱导的运动亢进是必要的。多巴胺D2受体在介导NGF的行为作用中似乎比多巴胺D1受体更重要。